T0	Interventions 0 3	PSK
T1	Interventions 130 229	oral adjuvant immunochemotherapy with protein-bound polysaccharide K (PSK) and tegafur/uracil (UFT)
T2	Interventions 309 319	UFT alone.
T3	Interventions 320 323	PSK
T4	Interventions 553 556	PSK
T5	Interventions 882 913	PSK plus 300 mg UFT (PSK group)
T6	Interventions 924 933	UFT alone
T7	Interventions 1136 1139	PSK
T8	Interventions 1172 1185	control group
T9	Interventions 1498 1501	PSK
T10	Interventions 1938 1947	PSK + UFT
T11	Interventions 2116 2119	PSK